New obesity drug shows promise in early trial
NCT ID NCT07431086
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug, olatorepatide, for weight loss in people who are overweight or obese but do not have diabetes. The drug works by targeting hormones that control appetite and blood sugar. Researchers will check how safe the drug is, how the body processes it, and how much weight participants lose compared to those taking a placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVERWEIGHT OR OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site Partners, LLC DBA Flourish Research
Winter Park, Florida, 32789, United States
-
Diablo Clinical Research - Flourish Research
Walnut Creek, California, 94598, United States
-
Flourish Research - San Antonio Medical Trials
San Antonio, Texas, 78229, United States